Christina Coughlin (@coughlin582) 's Twitter Profile
Christina Coughlin

@coughlin582

Oncologist and immunologist, believing that the cure lies within the immune system. CEO, Drug developer, dog lover, Philly sports fan and mom. Tweets are my own

ID: 1639384429

calendar_today02-08-2013 02:14:13

735 Tweet

1,1K Followers

748 Following

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

The evolution of preCISION is being unveiled today in Barcelona. We believe the future of cancer therapy means not having to choose between eliminating the disease and safeguarding patient wellness. We believe in hope without compromise. #PeptidesCreateHope #LetsDoThis #AVCT

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

Our goal is to deliver hope without compromise. Patient advocates make the world go round …. Thus we met with the SPAGN team at #CTOS2024 today to discuss FAP-Dox (AVA6000) and its role in sarcoma #PeptidesCreateHope #LetsDoThis

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

Pete is welcome in Philly anytime and we would love to have you too Kirk Herbstreit … Your best line of the game was “Philly makes them pay” …. Call an Philadelphia Eagles game anytime. Missing Ben too. Ben was #AmericasFootballDog. #GoBirds

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

Very excited to welcome Michelle to the team and happy to introduce her to the Avacta audience. #HopeWithoutCompromise #LetsDoThis

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

We are thrilled to welcome Brian to the Leadership team at Avacta. His knowledge and experience will combine to do great things for the Company Welcome to Avacta Brian! #PeptidesCreateHope #LetsDoThis #HopeWithoutCompromise

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

We are thrilled to announce our new data. It is early days in this setting … but AVA6000 is showing some exciting new data in salivary gland cancer, a disease with no standard therapy #AVCT #HopeWithoutCompromise #PeptidesCreateHope #LetsDoThis

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

Avacta #AVCT pleased to announce three presentations at #AACR25 to showcase the pre|CISION platform and pipeline #PeptidesCreateHope #LetsDoThis

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

Introducing our fantastic chemistry team. And why I call our second drug FAP-EXd “the beast” #PeptidesCreateHope #HopeWithoutCompromise #AVCT #LetsDoThis

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

Delighted to be at #BiotechWeekBoston connecting with industry and highlighting the great progress preCISION continues to make in clinic. #AVCT Avacta #LetsDoThis #PeptidesCreateHope #HopeWithoutCompromise

Delighted to be at #BiotechWeekBoston connecting with industry and highlighting the great progress preCISION continues to make in clinic. #AVCT <a href="/avacta/">Avacta</a>
#LetsDoThis
#PeptidesCreateHope 
#HopeWithoutCompromise
Christina Coughlin (@coughlin582) 's Twitter Profile Photo

Well that works. A W in the series against New York. Like any Phillies fan I hate the Mets. Good to take this one!! Go Phils!!

Christina Coughlin (@coughlin582) 's Twitter Profile Photo

#AVCT operates in a technical space with specific oncology criteria applied to every trial globally. Termed “RECIST” or “response evaluation criteria in solid tumors” … Ruairidh and I break this down in Pt 1. This is part 1. Next we will talk though durability and survival.